Companies/AU/CUV

CLINUVEL PHARMACEUTICALS LIMITED

Executives 5Directors 6Avg age 53Avg tenure 5.3y

Philippe Wolgen

Chief Executive Officer

Age 63Since 2005-10-31Profile →

Executives5

Philippe Wolgen

Chief Executive Officer

Age 63Since 2005-10-31

Director of Finance/CFO

Age 42Since 2024-06-29

Emilie Rodenburger

Chief Tech/Sci/R&D Officer

Chief Executive Officer

—Since 2025-03-17

Chief Tech/Sci/R&D Officer

Board of directors6

Karen Agersborg

Director/Board Member

Since 2018-01-28

Director/Board Member

Since 2019-09-22

Jeffrey Rosenfeld

Since 2023-12-31

Matthew Pringle

Director/Board Member

Since 2024-09-05

Guy van Dievoet

Director/Board Member

Since 2024-09-05

Director/Board Member

Since 2024-09-05

Shareholders5

Name	Stake	Shares
Philippe Wolgen	6.792 %	3,425,222
Ender 1 LLC	5.138 %	2,590,824
Emilino Group Pty Ltd.	1.19 %	600,000
Mark Edwin Badcock	0.5359 %	270,255
Darren Keamy	0.4817 %	242,890

Catalog · 2026-07-09

Registry officers11

Name	Role	Since	Shares
Dennis Wright	Chief Tech/Sci/R&D Officer	—	-
Emilie Rodenburger	Chief Tech/Sci/R&D Officer	—	-
Jeffrey Rosenfeld	Chairman	2023-12-31	-
Lachlan Hay	Chief Executive Officer	2025-03-17	-
Peter Vaughan	Director of Finance/CFO	2024-06-29	-
Philippe Wolgen	Chief Executive Officer	2005-10-31	-
Guy van Dievoet	Director/Board Member	2024-09-05	-
Karen Agersborg	Director/Board Member	2018-01-28	-

Registry · as of 2026-07-09